MRI shows drugs that can prevent heart damage in breast cancer patients

Jodelle Maglaya | | Health Imaging | Diagnostic Imaging

Researchers who led a new landmark clinical trail using carding MRI found that combining heart medication with chemotherapy reduces the risk of heart damage in patients with early-stage breast cancer.

The new five year study at the University of Alberta and Alberta Health Services found that beta blockers and ACE inhibitors, effectively prevent a drop in heart function from cancer treatment.  

The study is funded by the Canadian Institutes of Health Research (CIHR) and Alberta Cancer Foundation.  

Read the full article here:

Drugs prevent heart damage during breast cancer treatment, study show

Jodelle Maglaya

Jodelle joined TriMed Media Group in 2016 as a senior writer, focusing on content for Radiology Business and Health Imaging. After receiving her master's from DePaul University, she worked as a news reporter and communications specialist.

Related Content

AI rules out abnormal findings on chest X-rays, significantly reducing workloads
Older adults among the walking wounded with incident TBI
Philips moves digital pathology to the cloud with AWS
PHOTO GALLERY: What does fetal medical imaging look like?
Speaker laments radiology’s major contribution to climate change
Radiologist accuracy takes a hit overnight, especially with advanced imaging exams

Around the web

Radiology Business
AI can help radiology standardize image exam data labeling

To fully leverage today's radiology IT systems, standardization is a necessity. Steve Rankin, chief strategy officer for Enlitic, explains how artificial intelligence can help.

Radiology Business
The biggest obstacles facing radiology business managers in 2025

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.